Cargando…
Correction: Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma
Autores principales: | Lämmer, Friederike, Delbridge, Claire, Würstle, Silvia, Neff, Frauke, Meyer, Bernhard, Schlegel, Jürgen, Kessel, Kerstin A., Schmid, Thomas E., Schilling, Daniela, Combs, Stephanie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951894/ https://www.ncbi.nlm.nih.gov/pubmed/33705498 http://dx.doi.org/10.1371/journal.pone.0248612 |
Ejemplares similares
-
Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma
por: Lämmer, Friederike, et al.
Publicado: (2019) -
High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients
por: Hönikl, Lisa Stefanie, et al.
Publicado: (2020) -
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
por: Straube, Christoph, et al.
Publicado: (2020) -
Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine
por: Wank, Michaela, et al.
Publicado: (2018) -
HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2022)